Population-based incidence and risk factors for cholestasis in hemolytic disease of the fetus and newborn
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-5543
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Population-based incidence and risk factors for cholestasis in hemolytic disease of the fetus and newborn ; volume:42 ; number:6 ; day:22 ; month:2 ; year:2022 ; pages:702-707 ; date:6.2022
Journal of perinatology ; 42, Heft 6 (22.2.2022), 702-707, 6.2022
- Urheber
-
Teng, Jonas
Wickman, Linnéa
Reilly, Marie
Nemeth, Antal
Fischler, Björn
Bohlin, Kajsa
Tiblad, Eleonor
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41372-022-01345-1
- URN
-
urn:nbn:de:101:1-2022080607410276207437
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:38 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Teng, Jonas
- Wickman, Linnéa
- Reilly, Marie
- Nemeth, Antal
- Fischler, Björn
- Bohlin, Kajsa
- Tiblad, Eleonor
- SpringerLink (Online service)
Ähnliche Objekte (12)
Laboratory Monitoring of Mother, Fetus, and Newborn in Hemolytic Disease of Fetus and Newborn
Hemolytic Disease of the Fetus and Newborn due to Intravenous Drug Use
Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape
Hemolytic disease of the fetus and newborn: rapid review of postnatal care and outcomes
Identifying Hemolytic Disease of the Fetus and Newborn within a Large Integrated Health Care System
Hemolytic disease of the fetus and newborn and Rhesus alloimmunization in Latin American countries: a scoping review
Hemolytic disease of the fetus and newborn caused by anti-D and anti-S alloantibodies: a case report
Absence of hemolytic disease of fetus and newborn (HDFN) in a pregnancy with anti-Yka (York) red cell antibody
Hemolytic Disease of the Fetus and Newborn: Understanding the Testing Needed to Confirm the Identity of the Causative Antibody
Infections of the Fetus and Newborn Infant
In Response: Hemolytic Disease of the Fetus and Newborn: Understanding the Testing Needed to Confirm the Identity of the Causative Antibody
Physiology of the ductus arteriosus in the fetus and newborn
Laboratory Monitoring of Mother, Fetus, and Newborn in Hemolytic Disease of Fetus and Newborn
Hemolytic Disease of the Fetus and Newborn due to Intravenous Drug Use
Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape
Hemolytic disease of the fetus and newborn: rapid review of postnatal care and outcomes
Identifying Hemolytic Disease of the Fetus and Newborn within a Large Integrated Health Care System
Hemolytic disease of the fetus and newborn and Rhesus alloimmunization in Latin American countries: a scoping review
Hemolytic disease of the fetus and newborn caused by anti-D and anti-S alloantibodies: a case report
Absence of hemolytic disease of fetus and newborn (HDFN) in a pregnancy with anti-Yka (York) red cell antibody
Hemolytic Disease of the Fetus and Newborn: Understanding the Testing Needed to Confirm the Identity of the Causative Antibody
Infections of the Fetus and Newborn Infant
In Response: Hemolytic Disease of the Fetus and Newborn: Understanding the Testing Needed to Confirm the Identity of the Causative Antibody
Physiology of the ductus arteriosus in the fetus and newborn
Laboratory Monitoring of Mother, Fetus, and Newborn in Hemolytic Disease of Fetus and Newborn
Hemolytic Disease of the Fetus and Newborn due to Intravenous Drug Use
Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape
Hemolytic disease of the fetus and newborn: rapid review of postnatal care and outcomes
Identifying Hemolytic Disease of the Fetus and Newborn within a Large Integrated Health Care System
Hemolytic disease of the fetus and newborn and Rhesus alloimmunization in Latin American countries: a scoping review
Hemolytic disease of the fetus and newborn caused by anti-D and anti-S alloantibodies: a case report
Absence of hemolytic disease of fetus and newborn (HDFN) in a pregnancy with anti-Yka (York) red cell antibody
Hemolytic Disease of the Fetus and Newborn: Understanding the Testing Needed to Confirm the Identity of the Causative Antibody
Infections of the Fetus and Newborn Infant
In Response: Hemolytic Disease of the Fetus and Newborn: Understanding the Testing Needed to Confirm the Identity of the Causative Antibody